LakeShore Biopharma Co., Ltd. (LSBCF) — Earnings Call Analysis & IR Page

LakeShore Biopharma Co., Ltd is a Healthcare company operating in Biotechnology with a $2.8M market cap.

Most recent earnings call: Q3 FY24 on Apr 19, 2024.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.68

investors.lakeshorebio.com/index.html

Extracted from Unknown source, 2026-06-21.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 1 calls

Q3 FY2024
Earnings
2024-04-195 Q&A exchanges

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LSBCF.

$ curl https://api.spokenalpha.com/v1/companies/LSBCF

Get an API key API docs

FAQ

Frequently asked about LSBCF

Where can I find LakeShore Biopharma Co., Ltd.'s (LSBCF) earnings call transcripts?

Spoken Alpha indexes LSBCF's earnings call transcripts at https://spokenalpha.com/companies/LSBCF. Each call links to attributed speakers and parsed analyst Q&A.

When was LakeShore Biopharma Co., Ltd.'s most recent earnings call?

LakeShore Biopharma Co., Ltd. (LSBCF) held its most recent earnings call on 2024-04-19, covering fiscal Q3 2024.

What sector is LSBCF in?

LakeShore Biopharma Co., Ltd. (LSBCF) operates in the Healthcare sector (Biotechnology industry).

Overview